A randomized, crossover trial comparing the efficacy and safety of fesoterodine and extended-release...
A randomized, crossover trial comparing the efficacy and safety of fesoterodine and extended-release oxybutynin in children with overactive bladder with 12-month extension on fesoterodine: The FOXY study: Long-acting antimuscarinics for pediatric detrusor overactivity
About this item
Full title
Author / Creator
Journal title
Language
English
Formats
More information
Scope and Contents
Contents
Introduction: We sought to assess and compare safety and efficacy of fesoterodine and oxybutynin extended-release in the treatment of pediatric overactive bladder (OAB).
Methods: We conducted a non-inferiority, randomized, double-blind, crossover trial comparing fesoterodine 4–8 mg and oxybutynin 10–20 mg QD in children with OAB aged 5–14 years...
Alternative Titles
Full title
A randomized, crossover trial comparing the efficacy and safety of fesoterodine and extended-release oxybutynin in children with overactive bladder with 12-month extension on fesoterodine: The FOXY study: Long-acting antimuscarinics for pediatric detrusor overactivity
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_crossref_primary_10_5489_cuaj_6247
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_primary_10_5489_cuaj_6247
Other Identifiers
ISSN
1911-6470
E-ISSN
1920-1214
DOI
10.5489/cuaj.6247
